RELX PLC PLC American Depositary Shares (Each representing One Ordinary Share) (RELX) Company Bio
RELX PLC provides information solutions for professional customers in North America and Europe. The companys Scientific, Technical & Medical segment publishes research, reference, and education content; and offers database and workflow solutions for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive corporations, and governments. The company was founded in 1894 and is based in London, United Kingdom.
RELX Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Relx Plc. To summarize, we found that Relx Plc ranked in the 36th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 20.5%. The most interesting components of our discounted cash flow analysis for Relx Plc ended up being:
83% of the company's capital comes from equity, which is greater than 68.38% of stocks in our cash flow based forecasting set.
Relative to other stocks in its sector (Consumer Cyclical), Relx Plc has a reliance on debt greater than only 16.77% of them.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
HD, HHS, AMC, DPZ, and JW.A can be thought of as valuation peers to RELX, in the sense that they are in the Consumer Cyclical sector and have a similar price forecast based on DCF valuation.